Insider buying
~$46K30K sh @ $1.55
Traded Dec 2, 2024 · filed 2 days later
An Alx Oncology director paid $46K out of pocket for Alx Oncology shares. It was the first purchase in over a year. Shares held went up 1000% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
3 tracked managers disclosed the same change for Q3 2024. From a 13F filed Nov 14, 2024 covering holdings at Sep 30, 2024 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Exited
Compared with the manager's Q2 2024 13F
1,575,605
0
−100.0%
Share count drives classification; reported value also moves with price
3
For Q3 2024
Insider buying
Traded Dec 2, 2024 · filed 2 days later
An Alx Oncology director paid $46K out of pocket for Alx Oncology shares. It was the first purchase in over a year. Shares held went up 1000% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.